Cargando…
Recent advances in the treatment of Clostridioides difficile infection: the ever-changing guidelines
Clostridioides difficile infection (CDI), formerly known as Clostridium difficile, continues to be the most common healthcare-associated infection worldwide. With the shifting epidemiology towards higher a incidence of community-acquired CDI and the continued burden on the healthcare system posed by...
Autores principales: | Khurana, Shruti, Kahl, Alyssa, Yu, Kevin, DuPont, Andrew W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886080/ https://www.ncbi.nlm.nih.gov/pubmed/33659945 http://dx.doi.org/10.12703/b/9-13 |
Ejemplares similares
-
Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients
por: Ali, Hiba, et al.
Publicado: (2021) -
Clostridioides difficile therapeutics: guidelines
and beyond
por: Orenstein, Robert, et al.
Publicado: (2019) -
Evolution of clinical guidelines for antimicrobial management of Clostridioides difficile infection
por: Chaar, Abdelkader, et al.
Publicado: (2021) -
Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection
por: Gu, Ting, et al.
Publicado: (2022) -
Treatment of Clostridioides difficile infection: from guidelines to clinical practice
por: Merino, Esperanza, et al.
Publicado: (2022)